Author: Jason Knight

FDA approves DVT prevention device

    California-based ManaMed has launched the U.S. Food and Drug Administration (FDA) approved deep vein thrombosis (DVT) prevention device PlasmaFlow in the United States. The portable, tubeless and digital PlasmaFlow, which comes with multiple pressure functions, helps to prevent the onset…

    Reva scaffolding study yields good results

      As some companies have worked to improve drug-eluting stents by making them bioresorbable, some voices in the coronary intervention space have expressed concern over the rates of late stent thrombosis and repeat percutaneous coronary intervention seen with the devices. In…

      Access Vascular HydroPICC cath raises $4M

        Medical device developer Access Vascular has raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk. The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the…

        Thrombectomy device market to reach $1.45B value by 2022

          The global thrombectomy devices market is expected to reach a value of $1.45 billion by 2022, growing at a CAGR of 6.7 percent during the forecast period, according to a new Research and Markets report, “Thrombectomy Devices Market – Global…

          ElastiMed raises $1M in second funding round

            In its second round of funding in October, Israeli medical startup ElastiMed has raised $1 million from a strategic investor, existing investors — The Trendlines Group and Pix Vine Capital — new private investors, and the Israeli Innovation Authority. ElastiMed, which…